Neuralink’s “Disadvantaged Business” Filing: A Look at Musk’s Strategy and Systemic Exploitation
Neuralink, Elon Musk’s health tech company, filed as a “small disadvantaged business” with the U.S. Small Business Administration shortly before a financing round that valued the company at $9 billion. This designation, which could provide preferential access to federal procurement opportunities, requires the company to be at least 51% owned and controlled by “disadvantaged” individuals. The filing, which listed Neuralink executive Jared Birchall as the contact person, occurred during a period when Musk was leading the Trump administration’s Department of Government Efficiency, which targeted diversity, equity, and inclusion initiatives. The company’s technology aims to develop a brain-computer interface (BCI) system to help people with severe paralysis.
John Q. Hosedrinker